Home » Watson Laboratories Sends Patent Challenge Notice to Ranbaxy for Acne Drug
Watson Laboratories Sends Patent Challenge Notice to Ranbaxy for Acne Drug
Ranbaxy’s U.S. branch has received a notice from Watson Laboratories challenging the former over a patent for acne drug Absorica.
The Economic Times
The Economic Times
Upcoming Events
-
07May
-
14May
-
30May